Top Overvalued Biotechnology industry Stocks 2026

Revolution Medicines, (RVMD) has the largest fair value gap in the Biotechnology industry at 99.4% above the modeled estimate, followed by Forte Biosciences, (FBRX) at 99.3%, Oruka Therapeutics, (ORKA) at 99.1%, and Centessa Pharmaceuticals (CNTA) at 98.8%.

Updated todayBased on intrinsic value modelsIndustry: Biotechnology

Page snapshot: 6 Oct 2026, 7:00 am

View full analysis in the screener → · All overvalued →

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Compare price vs fair value See intrinsic value →

Biotechnology Industry Valuation Insights (Updated Today)

The Biotechnology industry currently shows an average fair value gap of 84.9% on this snapshot.
Top name Revolution Medicines, Inc. (RVMD) trades at roughly a 99.4% gap versus modeled intrinsic value—rankings move with prices and inputs.
This industry's average fair value gap is below our broad benchmark (~94.5%).

Overvalued Biotechnology Stocks by Market Cap

Large cap (top 5)

1.Revolution Medicines, Inc. · RVMD99.4%$43.93B
2.Summit Therapeutics Inc. · SMMT97.9%$13.37B
3.Roivant Sciences Ltd. · ROIV80.9%$25.8B
4.Verona Pharma plc · VRNA67.1%$72.68B

Mid cap (top 5)

1.Oruka Therapeutics, Inc. · ORKA99.1%$5.1B
2.Centessa Pharmaceuticals plc · CNTA98.8%$6.27B
3.Spyre Therapeutics, Inc. · SYRE98.7%$8.09B
4.Cogent Biosciences, Inc. · COGT97.7%$5.3B
5.Scholar Rock Holding Corporation · SRRK96.4%$5.61B

Small cap (top 5)

1.Forte Biosciences, Inc. · FBRX99.3%$1.58B
2.Tourmaline Bio, Inc. · TRML97.5%$1.23B
3.Eton Pharmaceuticals, Inc. · ETON95.0%$1.52B
4.Zenas BioPharma, Inc. · ZBIO88.9%$1.79B
5.Stoke Therapeutics, Inc. · STOK80.6%$1.65B

What Are Overvalued Biotechnology Stocks?

Overvalued biotechnology stocks are names where price sits above modeled fair (intrinsic) value—shown as a fair value gap versus the current quote.

This is not a sell list. Validate each symbol on its company page before you act.

How We Identify Overvalued Biotechnology Stocks

We pull an industry-filtered overvalued snapshot (price, fair value gap, cap, sector, country) and rank by that gap. You can sort and search in the table above.

Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.

FAQs

Answers about overvalued biotechnology names, intrinsic value, and how often this list refreshes.

What are overvalued biotechnology stocks?

They are Biotechnology names trading above modeled intrinsic value—shown here as a fair value gap versus price. Models vary; use this as a screen, not advice.

How do you find overvalued biotechnology stocks?

We load overvalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.

Why are biotechnology stocks overvalued?

Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.

Is this biotechnology list a recommendation to buy or sell?

No. Rankings are by calculated gap versus a model. A premium can reflect growth expectations or data lag. Check fundamentals; seek licensed advice for personal decisions.

How often is this list updated?

The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.